Bo. Jacobsson - Gynecology

Author Information

Bo Jacobsson is a distinguished researcher affiliated with the Department of Obstetrics and Gynecology at Sahlgrenska University Hospital/Östra in Gothenburg, Sweden. His research primarily focuses on various aspects of obstetrics and gynecology, including preterm delivery, intra-amniotic inflammation, cervical neoplasia, and related areas.

Research Contributions

In 2022, Bo Jacobsson significantly contributed to the field through multiple impactful studies. His research includes exploring the associations between cervical intraepithelial neoplasia during pregnancy and preterm delivery, developing experimental models for intra-amniotic inflammation, and assessing the cost-effectiveness of cervical length screening and progesterone treatment. Additionally, his studies on calprotectin levels in amniotic fluid, genetic architecture of infant and early childhood body mass index, and the virulence factors of invasive Group B Streptococcus provide valuable insights into maternal and neonatal health.

Aliases

Bo Jacobsson has published under various names, including B Jacobsson, B. Jacobsson, and Bo. Jacobsson.

Publication and Citation Metrics

Metric	Value
Citation Count	22,766
h-index	66
Paper Count	418

Publications:

Associations between cervical intraepithelial neoplasia during pregnancy, previous excisional treatment, cone-length and preterm delivery: a register-based study from western Sweden

DOI: 10.1186/s12916-022-02276-6

Year: 2022

Development of a Rat Model of Intra-Amniotic Inflammation via Ultrasound-Guided Administration of a Triggering Agent in the Gestational Sac to Enable Analysis of Individual Amniotic Fluid Samples

DOI: 10.3389/fphar.2022.871193

Year: 2022

Calprotectin levels in amniotic fluid in relation to intra-amniotic inflammation and infection in women with preterm labor with intact membranes: A retrospective cohort study.

DOI: 10.1016/j.ejogrb.2022.03.006

Year: 2022

Cost-effectiveness of cervical length screening and progesterone treatment to prevent spontaneous preterm delivery in Sweden.

DOI: 10.1002/uog.24884

Year: 2022

Response: FIGO good practice recommendations on the use of pessary for reducing the frequency and improving outcomes of preterm birth

DOI: 10.1002/ijgo.14105

Year: 2022

Characterization of the genetic architecture of infant and early childhood body mass index.

DOI: 10.1038/s42255-022-00549-1

Year: 2022

Virulence Factors of Invasive Group B Streptococcus Isolates Obtained from Pregnant Women and Neonates

DOI: 10.1016/j.ajog.2021.11.1295

Year: 2022

Clinical characteristics of colonization of the amniotic cavity in women with preterm prelabor rupture of membranes, a retrospective study

DOI: 10.1038/s41598-022-09042-x

Year: 2022

Prevalence and Load of Cervical Ureaplasma Species With Respect to Intra-amniotic Complications in Women With Preterm Prelabor Rupture of Membranes Before 34 weeks

DOI: 10.3389/fphar.2022.860498

Year: 2022

Assessment of Joint Impact of Iodine, Selenium, and Zinc Status on Women's Third-Trimester Plasma Thyroid Hormone Levels.

DOI: 10.1093/jn/nxac081

Year: 2022

What are Common Barriers to Compliance?

What Causes Undervirilization?

What is a Biomarker?

What are Multiplex Assays?

How can women manage menstrual pain?

What is Cross Reactivity?

How Often Should Women Engage in Cardiovascular Exercise?

What are common gynecological issues that can be prevented?

Why are UTIs more common in women?

Who Can Use Natural Family Planning?

Partnered Content Networks

Relevant Topics